Evidence map›Paper›PMID 18790666›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2008

Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Ke Lan, Masanao Murakami, Tathagata Choudhuri, Donald E Tsai, Stephen J Schuster, Mariusz A Wasik, Erle S Robertson

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ke LanDepartment of Microbiology and the Tumor Virology Program of Abramson Comprehensive Cancer Center, University of Pennsylvania Medical School, 201E Johnson Pavilion, Philadelphia, PA 19104, U S.
Masanao Murakami
Tathagata Choudhuri
Donald E Tsai
Stephen J Schuster
Mariusz A Wasik
Erle S Robertson
University of Pennsylvania · USHospital of the University of Pennsylvania · USChinese Academy of Sciences · CN

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Role of LANA-RBP-jk During Early KSHV InfectionP01CA174439 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2018
$8.7M
Mechanisms of Action of LANA encoded by KSHVR01CA091792 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2002 to 2011
$3.4M
Mechanism of EBNA mediated cell migrationR01CA108461 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2004 to 2008
$1.7M
EBV Associated Head and Neck CancersR01DE014136 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S · 2001 to 2005
$1.4M
KSHV genome modification in KS tissueR01CA177423 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2013 to 2015
$594k
NCI NIH HHS CA072510NCI NIH HHS CA091792NCI NIH HHS P01 CA174439NCI NIH HHS R01 CA091792NCI NIH HHS R01 CA108461NCI NIH HHS R01 CA177423NIDCR NIH HHS DE014136-04NIDCR NIH HHS R01 DE014136NIDDK NIH HHS P30 DK050306
6 · The paper itself

Abstract

backgroundEpstein-Barr virus (EBV) is closely associated with the development of a number of tumors. During latent infection, EBV continuously expresses a number of viral genes which are essential for cell transformation and maintenance of the malignant phenotype of EBV-related tumors. There has been no previous link between EBV and T-cell prolymphocytic leukemia (T-PLL), a distinctive form of leukemia derived from T-cells at an intermediate stage of differentiation between a cortical thymocyte and a mature peripheral blood T-cell.

objectiveTo determine if EBV was present in the T-PLL cells collected. STUDY

designT-PLL cells were isolated from the peripheral blood of a patient diagnosed with T-PLL and continuously cultured for about 1 year. The existence of EBV in these cells was detected using multiple strategies including PCR, Western blotting, immunofluorescent assay and flow cytometry analysis.

resultsThe EBV genome was present in these T-PLL cells by PCR analysis across multiple sites in the viral genome. In addition, these T-PLL cells expressed a number of EBV latent antigens. The EBV oncoproteins LMP1, EBNA1 and EBNA3C were expressed in the majority of the infected cells.

conclusionThis report suggests a potential link between EBV infection and T-PLL and provides new information about the potential contribution of EBV in the initiation or maintenance of T-PLL.

Indexed as

AgedAntigens, ViralBlotting, WesternCells, CulturedDNA, ViralFlow CytometryHerpesvirus 4, HumanHumansLeukemia, Prolymphocytic, T-CellMaleMicroscopy, FluorescencePolymerase Chain ReactionAntigens, ViralDNA, Viral

Identifiers

PMID18790666
PMCPMC4289600
OpenAlexW2150813843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.